면역세포의 면역조절 유전자의 활성 조절을 위한 조성물 및 그 용도
    2.
    发明公开
    면역세포의 면역조절 유전자의 활성 조절을 위한 조성물 및 그 용도 审中-公开
    用于调节免疫细胞中免疫调节基因活性的组合物及其用途

    公开(公告)号:KR20180018466A

    公开(公告)日:2018-02-21

    申请号:KR20170149914

    申请日:2017-11-10

    CPC classification number: Y02A50/47

    Abstract: 면역조절유전자가불활성화된면역세포, 이를포함하는약학조성물, 면역세포에서의면역조절유전자불활성화에적용가능한가이드 RNA, 상기가이드 RNA 또는이를암호화하는핵산분자와 RNA-가이드엔도뉴클레아제또는이를암호화하는핵산분자를포함하는면역세포유전체교정용조성물및 이를이용하는방법이제공된다.

    Abstract translation: 免疫调节基因是失活的免疫细胞,含有它们的药物组合物,免疫调节eseoui基因的光施加到可活化引导RNA,引导RNA或核酸分子和RNA-指导编码所述核酸内切酶相同,或者它加密免疫细胞 以及使用它的方法。

    Oleic acid-enriched plant body having genetically modified FAD2 and production method thereof

    公开(公告)号:AU2022204029B2

    公开(公告)日:2024-12-19

    申请号:AU2022204029

    申请日:2022-06-09

    Abstract: The present invention relates to an artificially manipulated unsaturated fatty acid biosynthesis-associated factor and use thereof to increase the content of a specific unsaturated fatty acid of a plant body. More particularly, the present 5 invention relates to a system capable of artificially controlling unsaturated fatty acid biosynthesis and a plant body produced thereby, which include an artificially manipulated unsaturated fatty acid biosynthesis-associated factor to control unsaturated fatty acid biosynthesis and a composition capable of artificially manipulating the factor. In a specific aspect, the present invention relates to 10 artificially manipulated unsaturated fatty acid biosynthesis-associated factors such as FAD2, FAD3, FAD6, FAD7 and FAD8 and/or an unsaturated fatty acid biosynthesis controlling system by an expression product thereof.

    Artificially engineered SC function control system

    公开(公告)号:AU2017358122B2

    公开(公告)日:2022-12-22

    申请号:AU2017358122

    申请日:2017-09-28

    Abstract: The present invention relates to an artificially engineered SC function control factor for SC function control and/or the treatment or alleviation of a disease due to SC function disorder, and to a use thereof. More specifically, the present invention relates to a system capable of performing artificial SC function control and/or treating or alleviating a disease due to SC function disorder, the system comprising: an artificially engineered SC function control factor for SC function control and/or the treatment or alleviation of a disease due to SC function disorder; and/or a composition capable of artificially engineering an SC function control factor. In a specific aspect, the present invention relates to an SC function control system by an SC function control factor, such as artificially engineered PMP22, and/or an expression product thereof.

Patent Agency Ranking